Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages, Blood, vol.127, issue.22, pp.2672-2681, 2016. ,
Histiocytoses: emerging neoplasia behind inflammation, Lancet Oncol, vol.18, issue.2, pp.113-125, 2017. ,
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other nonLangerhans cell histiocytoses Brief report High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other nonLangerhans cell histiocytoses, Blood, vol.120, issue.13, pp.2700-2703, 2012. ,
Frequent detection of BRAF V 600E mutations in histiocytic and dendritic cell neoplasms, Histopathology, vol.65, issue.2, pp.261-272, 2014. ,
Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis, Blood, vol.124, pp.3007-3015, 2014. ,
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation, Blood, vol.121, issue.9, pp.1495-1500, 2013. ,
Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations, N Engl J Med, vol.373, issue.8, pp.726-736, 2015. ,
Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease, Blood, vol.124, pp.3016-3019, 2014. ,
Diverse and targetable kinase alterations drive histiocytic neoplasms, Cancer Discov, vol.6, issue.2, pp.154-165, 2016. ,
Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes, JCI Insight, vol.2, issue.3, p.89473, 2017. ,
Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease, Mod Pathol, vol.30, issue.10, pp.1367-1377, 2017. ,
Is Rosai-Dorfman disease a reactve process? Detection of a MAP2K1 L115V mutation in a case of Rosai-Dorfman disease, Virchows Arch, vol.471, issue.4, pp.545-547, 2017. ,
Rosai-Dorfman disease with activating KRAS mutation -response to cobimetinib, N Engl J Med, vol.377, issue.24, pp.2398-2399, 2017. ,
How I treat Langerhans cell histiocytosis, Blood, vol.126, issue.1, pp.26-35, 2015. ,
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and nonpulmonary Langerhans cell histiocytosis, Leuk Lymphoma, vol.55, issue.11, pp.2620-2626, 2014. ,